Open in interactive viewer → charts, metric popovers & call review

Sdiptech’s Growth Engine Is Running Hot — and Its Cash Conversion Is Running Late

Q3 sales rose 19% and organic growth was 13%, but margin slipped to 20.0%, cash conversion fell to 62% and leverage hit 2.95x as management warned of a second raw-material inflation wave.
SDIP-B.ST · Earnings Call · 2026-10-23

Sdiptech’s Growth Engine Is Running Hot — and Its Cash Conversion Is Running Late

Sdiptech’s Q3 2026 report is a high-growth conglomerate print with a quality problem. Net sales rose 19% to just over SEK 1.3bn, organic growth was 13%, and all four business areas grew organically. Adjusted EBITA rose 11% to SEK 261m, but the adjusted EBITA margin fell to 20.0% from 21.3%. Cash conversion dropped to 62% in the quarter, and net debt/EBITDA rose to 2.95x against a 3.0x ceiling. Strong demand, weaker conversion and leverage at the limit — that is the real story.

Growth Is Real, but It Is Not Clean

The top line is broad. Supply Chain & Transportation grew sales 27% and adjusted EBITA 12%, but its margin fell to 18.5% from 21%. The global supply-chain theme is crowded — Supply Chain Solutions is near the top of the market keyword table — yet Sdiptech’s issue is not demand. It is margin execution. Two things hit the segment: a large Hilltip order for highway salt spreading equipment that included the truck and carried a lower margin, and Mecno, the Italian rail-equipment company, where key component costs rose during a year-long build and could not be passed through.

The main reason is Mecno... the cost for these key components has increased significantly during the year. Unfortunately, we have not been able to charge that to the customers, so it has been affecting the margin a lot.

Anders Mattson, CEO · 2026-10-23
That is a specific, company-level execution miss, not a sector demand problem. The rest of the portfolio was more encouraging. Safety & Security grew sales 9% and adjusted EBITA 31%, with a 36% margin, helped by scale, mix and a run of well-performing companies. But management was explicit that this is not the new normal: “these high margins will not be sustainable in the long term” — Anders Mattson, CEO · 2026-10-23. Energy & Electrification grew sales 17% and EBITA 9%, with Phase 3 benefiting from reliable power distribution and some data center demand. That data-center kicker is real but small; on the prior call the CFO downplayed it: “it's not that it would be a strong negative game changer if it wouldn't be there.” — Bengt Lejdström, CFO · 2026-07-17 Water & Bioeconomy finally returned to profit growth, with sales up 6% and EBITA up 2%, led by Auger’s 12% profit improvement.

The Cash Flow and Leverage Squeeze

The weaker cash flow is the hinge. Cash conversion was 62% in Q3 versus a 70%-90% target, though the rolling 12-month figure is still 81%. Management attributes the drop to inventory builds at Hilltip and Certus — the latter pre-buying a camera component against shortage risk — and to receivables from late-September sales. That explanation is plausible, but it is also familiar. On the prior call, the CFO described inventory build as seasonal: “When it comes to buildup of inventory, as I said, it's quite typical this time of year.” — Bengt Lejdström, CFO · 2026-07-17 The difference now is that the balance sheet has less room for the usual seasonal swing. Leverage rose to 2.95x, just below the leverage target ceiling of 3.0x. Two Q3 acquisitions added full debt but only partial profit, and the company also refinanced its bond — an early redemption of the old issue and a smaller new bond at a much lower margin, 200bp versus 490bp. That is smart long-term housekeeping, but it came with a penalty fee in the quarter. The cash-flow recovery in Q4 is now the swing factor: “Q4 is typically very strong because of these seasonal companies.” — Bengt Lejdström, CFO · 2026-10-23 If that release does not arrive, the M&A runway narrows.

Inflation Is the New Variable

The most important change versus the prior quarter is not demand. It is cost. In July, Anders Mattson said: “we haven't seen any specific price increases on, let's say, raw material side, not substantial at least.” — Anders Mattson, CEO · 2026-07-17 On this call the language shifted: “We talk a lot about that we foresee a second wave of inflation coming in now into the raw material situation.” — Anders Mattson, CEO · 2026-10-23 That is a genuine new risk for a decentralized conglomerate with long project cycles. Mecno is the cautionary example: a fixed-price, year-long build without indexation. Management says it is now adding raw-material indexation to larger projects and that the risk of a repeat is small, but the market should watch whether the raw material pressure stays isolated or spreads. The group’s decentralized model is a strength in many ways, but it also means pricing discipline varies company by company — and Mecno just showed what happens when a project misses that discipline.

M&A and the 2027 Promise

M&A remains the growth engine. Sdiptech has made five acquisitions over the last 12 months, including two in Q3 — A.U.T. and VALE Engineering, both U.K.-based, with roughly GBP 7m and GBP 5m in annual revenue and stable profitability. The pipeline is described as the strongest in a year, but the leverage ceiling forces discipline. The strategic roadmap is now explicit: 2025 was portfolio streamlining, 2026 is growth and balance-sheet repair, and 2027 is meant to deliver full potential — 15% growth and a rising return on capital employed. On the prior call, the CFO put the ROCE target on a one-to-two-year horizon: “this will take perhaps a year or 2 to reach that 15%.” — Bengt Lejdstrom, CFO · 2026-02-10 That is consistent with 2027, but it also means the next three quarters have to show cleaner conversion, not just top-line momentum. The quarter’s quality test is therefore simple. Demand is not the problem: all four business areas grew, Safety & Security is compounding at a high level, Energy & Electrification is riding electrification and some data center demand, and Water & Bioeconomy has returned to profit growth. The problem is that the group is converting too little of that growth into cash while carrying leverage near its ceiling. The bull case is that Q4 releases working capital, Mecno and Hilltip margins normalize, and the 2027 roadmap stays intact. The bear case is that the second inflation wave broadens, cash conversion stays below target, and Sdiptech has to choose between M&A and deleveraging. Q3 did not settle that debate — it sharpened it.